Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
MediGene
company
About
MediGene is a company that specializes in biotechnology specifically in the treatment of cancer.
- 51 - 100
Highlights
Details
- Last Funding Type
- Post-IPO Equity
- Last Funding Money Raised
- €26M
- Industries
- Biotechnology,Health Care,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 1994
- Number Of Employee
- 51 - 100
- Operating Status
- Active
MediGene is a company that specializes in biotechnology specifically in the treatment of cancer.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
€26M
MediGene has raised a total of
€26M
in funding over 2 rounds. Their latest funding was raised on
Feb 2, 2022 from a Post-IPO Equity round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 2, 2022 | Post-IPO Equity | €26M | 1 |
BioNTech
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
MediGene is funded by 1 investors.
BioNTech
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
BioNTech
|
Yes | Post-IPO Equity |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
